Anthem Inc (NYSE:ANTM) EVP Thomas C. Zielinski sold 7,826 shares of the stock in a transaction on Wednesday, November 7th. The stock was sold at an average price of $289.71, for a total transaction of $2,267,270.46. Following the sale, the executive vice president now directly owns 29,466 shares in the company, valued at $8,536,594.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Anthem stock traded down $0.31 during trading on Friday, hitting $287.06. 918,320 shares of the stock were exchanged, compared to its average volume of 1,597,366. The firm has a market capitalization of $74.99 billion, a P/E ratio of 23.84, a P/E/G ratio of 1.49 and a beta of 0.86. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.54 and a current ratio of 1.53. Anthem Inc has a 12 month low of $214.95 and a 12 month high of $290.84.
Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, October 31st. The company reported $3.81 EPS for the quarter, topping the consensus estimate of $3.70 by $0.11. The business had revenue of $22.98 billion during the quarter, compared to analyst estimates of $22.85 billion. Anthem had a net margin of 4.98% and a return on equity of 13.99%. The company’s quarterly revenue was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.65 earnings per share. As a group, sell-side analysts forecast that Anthem Inc will post 15.65 earnings per share for the current year.
A number of institutional investors and hedge funds have recently made changes to their positions in ANTM. Iridian Asset Management LLC CT boosted its position in shares of Anthem by 129.1% during the 3rd quarter. Iridian Asset Management LLC CT now owns 1,569,169 shares of the company’s stock valued at $430,031,000 after purchasing an additional 884,335 shares in the last quarter. Orbimed Advisors LLC bought a new position in shares of Anthem during the 2nd quarter valued at about $126,584,000. Artisan Partners Limited Partnership boosted its position in shares of Anthem by 40.2% during the 2nd quarter. Artisan Partners Limited Partnership now owns 1,788,388 shares of the company’s stock valued at $425,690,000 after purchasing an additional 512,962 shares in the last quarter. Bessemer Group Inc. boosted its position in shares of Anthem by 1,097.5% during the 2nd quarter. Bessemer Group Inc. now owns 463,480 shares of the company’s stock valued at $110,322,000 after purchasing an additional 424,775 shares in the last quarter. Finally, Sei Investments Co. boosted its position in shares of Anthem by 1,123.7% during the 2nd quarter. Sei Investments Co. now owns 427,853 shares of the company’s stock valued at $101,841,000 after purchasing an additional 392,889 shares in the last quarter. Hedge funds and other institutional investors own 86.81% of the company’s stock.
A number of brokerages have weighed in on ANTM. Jefferies Financial Group reissued a “buy” rating and set a $296.00 target price on shares of Anthem in a report on Thursday, July 26th. Credit Suisse Group increased their target price on shares of Anthem from $311.00 to $330.00 and gave the stock an “outperform” rating in a report on Thursday, November 1st. BMO Capital Markets increased their target price on shares of Anthem from $300.00 to $310.00 and gave the stock a “buy” rating in a report on Thursday, November 1st. Cantor Fitzgerald restated a “buy” rating and set a $275.00 price target on shares of Anthem in a research report on Thursday, October 25th. Finally, Morgan Stanley upped their price target on shares of Anthem from $269.00 to $273.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 26th. Four research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The company has an average rating of “Buy” and an average price target of $292.19.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: Conference Calls
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.